Fiscal year ending 2022. Filed on November 15, 2023.
121 E60th St 6a
New York, New York 10022
Biofoundation for Angiogenesis Research and Development (EIN: 31-6670928) has filed an IRS Form 990 from fiscal year 2020–2022. In its fiscal year 2022 IRS Form 990 filing, Biofoundation for Angiogenesis Research and Development, a 501(c)(3) charitable organization, reported compensation for 2 employees. Among the employees shown here, the average compensation is $0.
Revenue
Expenses
Employee compensation
THE FOUNDATION WAS ESTABLISHED FOR THE PURPOSE OF FINDING A MORE EFFECTIVE MEANS TO DIAGNOSE AND TREAT CANCER AND ARTHRITIS BY ANALYZING ANGIOGENESIS OF NEW BLOOD VESSEL (ANGIO) FORMATION (GENESIS).
Be the first to know when new IRS Form 990 data is published for this organization.